US Physical Therapy (USPH) Tops Q2 EPS by 25c; Raises Outlook
Get Alerts USPH Hot Sheet
Price: $78.71 -0.81%
Revenue Growth %: +8.5%
Financial Fact:
Net patient revenues: 86.41M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +8.5%
Financial Fact:
Net patient revenues: 86.41M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
US Physical Therapy (NYSE: USPH) reported Q2 EPS of $0.96, $0.25 better than the analyst estimate of $0.71. Revenue for the quarter came in at $126.93 million versus the consensus estimate of $121.35 million.
GUIDANCE:
Management increased its range of earnings guidance for full year 2021 to Operating Results per share of $3.05 to $3.15 from the previous range of $2.68 to $2.78 due to the Company’s strong performance in the 2021 Second Quarter, the impact of the acquisition closed in the 2021 Second Quarter an
For earnings history and earnings-related data on US Physical Therapy (USPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- BMO Capital Starts American Eagle Outfitters (AEO) at Market Perform
- ASP Isotopes holds first capital markets day, targets $300M EBITDA by 2031
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share